Functional genomics approaches to define new drug-targets for cancer therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/575581

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer is a deadly disease that results from the accumulation of genetic mistakes (mutations) that encourage cells to divide and spread. There are some key mutations that occur in many different types of cancer. My project aims to exploit this common blueprint to design drugs that will selectively kill cancer cells, while leaving normal cells unharmed. We will identify new drug targets for the treatment of breast, colon and lung cancer and assess these targets in a variety of model systems.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2014

Funding Scheme: Early Career Fellowships

Funding Amount: $374,797.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer | drug development | genetics | metastases

Related Links